Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Hester

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Drug Targeting|January 1, 1994
Epithelial cell permeability of a series of peptidic HIV protease inhibitors: aminoterminal substituent effectsR A Conradi, A R Hilgers, P S Burton, et al.
Journal of Medicinal Chemistry|June 1, 1989
1-(2-aminoethyl)-6-aryl-4H- [1,2,4]triazolo[4,3-a][1,4]benzodiazepines with diuretic and natriuretic activityJ B Hester, J H Ludens, D E Emmert, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
The evaluation of non-viral substrates of the HIV protease as leads in the design of inhibitors for AIDS therapyA G Tomasselli, J O Hui, T K Sawyer, et al.
Poultry Science|October 8, 1997
Development of a highly quantitative, reproducible assay for determination of chicken T cell growth factor biological activityJ L Pfohl, J B Hester, V W Doelling, et al.
International Journal of Peptide and Protein Research|September 1, 1992
HIV protease (HIV PR) inhibitor structure-activity-selectivity, and active site molecular modeling of high affinity Leu [CH(OH)CH2]Val modified viral and nonviral substrate analogsT K Sawyer, D J Staples, L Liu, et al.
Journal of Medicinal Chemistry|January 1, 1991
N-[(omega-amino-1-hydroxyalkyl)phenyl]methanesulfonamide derivatives with class III antiarrhythmic activityJ B Hester, J K Gibson, M G Cimini, et al.
Journal of Medicinal Chemistry|January 1, 1988
Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutionsT K Sawyer, D T Pals, B Mao, et al.
Journal of Medicinal Chemistry|April 12, 2001
Progress toward the development of a safe and effective agent for treating reentrant cardiac arrhythmias: synthesis and evaluation of ibutilide analogues with enhanced metabolic stability and diminished proarrhythmic potentialJ B Hester, J K Gibson, L V Buchanan, et al.
Journal of Medicinal Chemistry|March 15, 2000
Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalisM J Genin, D A Allwine, D J Anderson, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Drug Targeting|January 1, 1994
Epithelial cell permeability of a series of peptidic HIV protease inhibitors: aminoterminal substituent effectsR A Conradi, A R Hilgers, P S Burton, et al.
Journal of Medicinal Chemistry|June 1, 1989
1-(2-aminoethyl)-6-aryl-4H- [1,2,4]triazolo[4,3-a][1,4]benzodiazepines with diuretic and natriuretic activityJ B Hester, J H Ludens, D E Emmert, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
The evaluation of non-viral substrates of the HIV protease as leads in the design of inhibitors for AIDS therapyA G Tomasselli, J O Hui, T K Sawyer, et al.
Poultry Science|October 8, 1997
Development of a highly quantitative, reproducible assay for determination of chicken T cell growth factor biological activityJ L Pfohl, J B Hester, V W Doelling, et al.
International Journal of Peptide and Protein Research|September 1, 1992
HIV protease (HIV PR) inhibitor structure-activity-selectivity, and active site molecular modeling of high affinity Leu [CH(OH)CH2]Val modified viral and nonviral substrate analogsT K Sawyer, D J Staples, L Liu, et al.
Journal of Medicinal Chemistry|January 1, 1991
N-[(omega-amino-1-hydroxyalkyl)phenyl]methanesulfonamide derivatives with class III antiarrhythmic activityJ B Hester, J K Gibson, M G Cimini, et al.
Journal of Medicinal Chemistry|January 1, 1988
Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutionsT K Sawyer, D T Pals, B Mao, et al.
Journal of Medicinal Chemistry|April 12, 2001
Progress toward the development of a safe and effective agent for treating reentrant cardiac arrhythmias: synthesis and evaluation of ibutilide analogues with enhanced metabolic stability and diminished proarrhythmic potentialJ B Hester, J K Gibson, L V Buchanan, et al.
Journal of Medicinal Chemistry|March 15, 2000
Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalisM J Genin, D A Allwine, D J Anderson, et al.
Pageof 2